Sanofi to buy US biopharma group Blueprint for up to $9.5 billion
Blueprint is a specialist in treatments for systemic mastocytosis, a rare blood disorder.
The two companies said on Monday (Jun 2) that Sanofi would initially pay US$129.00 per share in cash, or around US$9.1 billion. Blueprint shares jumped 27 per cent to US$128.74 in premarket trade. Sanofi stock was down about 1 per cent.
Sanofi has ramped up research and development spending in recent years, prompting the company to abandon its long-term profit margin targets two years ago, as it seeks to build on the success of its blockbuster drug Dupixent for eczema and other conditions.
However, it suffered a setback last week after an experimental drug for patients with a lung condition commonly called 'smoker's lung' failed a late-stage trial.
The Blueprint acquisition 'represents a strategic step forward in our rare and immunology portfolios. It enhances our pipeline and accelerates our transformation into the world's leading immunology company,' said Sanofi CEO Paul Hudson.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Sign Up
Sign Up
The deal would add to Sanofi's portfolio the rare immunology disease drug Ayvakit, also known as Ayvakyt, approved in the US and the EU, and a promising advanced and early-stage immunology pipeline.
Ayvakit is the only approved medicine for advanced and indolent systemic mastocytosis, a rare blood disorder that occurs when the body makes abnormal mast cells – a type of white blood cell. It triggers a continuous allergic response.
The acquisition would also bring elenestinib, a next-generation medicine for systemic mastocytosis, as well as BLU-808, a highly selective and potent oral wild-type KIT inhibitor that has the potential to treat a broad range of diseases in immunology.
The deal makes 'strategic and financial sense', said JPMorgan analysts in a note, noting that Blueprint expects Ayvakit to reach annual sales of around US$2 billion by fiscal year 2030.
'We see the transaction as a good fit for Sanofi at a sensible valuation, which investors should see as a positive with time,' they added.
It is the latest in a series of deals by Sanofi. Last month, it announced the US$470 million purchase of Vigil Neuroscience and in January 2024 it struck a US$2.2 billion deal for US biotech firm Inhibrx.
Hudson said the deal complemented Sanofi's recent acquisitions of other early-stage medicines and added that it still retained a sizable capacity for further deals.
The company has said it plans to invest at least US$20 billion in the US through 2030 to boost manufacturing and research, joining other drugmakers in responding to President Donald Trump's drive to boost local manufacturing.
Besides US$129.00 per share in cash, Blueprint shareholders would also receive one non-tradeable contingent value right (CVR) per share, which would entitle the holder to receive two potential milestone payments of US$2 and US$4 per CVR for the achievement, respectively, of future development and regulatory milestones for BLU-808.
The total equity value of the transaction, including potential CVR payments, is US$9.5 billion on a fully diluted basis. It is expected to close in the third quarter, pending regulatory and shareholder approvals. REUTERS
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
12 minutes ago
- Straits Times
Electric ‘air taxis' could debut in Japan from 2027
Sign up now: Get ST's newsletters delivered to your inbox The aircraft, designed to carry a pilot and up to four passengers at speeds of up to 320kmh, could be in service from as early as 2027. TOKYO - Airline ANA said on Aug 7 that, together with a US start-up, it hopes to have electric 'air taxis' whizzing over Japan from as early as 2027. ANA and California-based Joby Aviation said they will establish a joint venture with a view to deploying more than 100 of the five-seater aircraft. Flying taxies will 'revolutionise our air mobility', Mr Koji Shibata, president and CEO of ANA, said in a statement on Aug 5. An ANA spokesman told AFP on Aug 7 that the aircraft, designed to carry a pilot and up to four passengers at speeds of up to 320kmh, could be in service from as early as 2027. The project primarily envisages trips between Narita and Haneda airports and Tokyo, although the routes can diversify in the future. Currently, a car or train ride between central Tokyo and Narita typically takes an hour or longer, but Joby's five-seater can shorten this to around 15 minutes, ANA said. There are no price details yet, but ANA wants to make the service as affordable as possible for the general public, a spokesman told AFP. ANA and Joby will make a public flight demonstration of the vehicles at the Osaka Expo in October. 'Where ancient wisdom, legendary craftsmanship and soaring ambition converge – that's Japan', said Mr JoeBen Bevirt, founder and CEO of Joby Aviation. 'And that makes it an extraordinary launchpad for redefining the future of air mobility'. Joby's aircraft lift off like a helicopter, then transition to fly forward like a plane 'with minimal acoustic impact and zero operating emissions', according to the firm. In December, flying taxi start-up Volocopter said it was filing for insolvency, days after another German company in the field, Lilium, was saved from collapse. Volocopter had been aiming to enter the market in 2025 with its two-seater 'Volocity' electric air taxi model. It suffered a setback when it had to cancel test flights in Paris during this summer's Olympics at short notice after the certification for its aircraft engine did not come through in time. AFP
Business Times
12 minutes ago
- Business Times
Singapore new corporate debt issuance up 34% to S$308 billion in 2024
[SINGAPORE] The corporate debt market saw robust growth in 2024, with new debt issuances rising 34 per cent year on year to S$308 billion. This comprises new issuances for short-term and long-term Singapore dollar and non-Singapore dollar debt, according to the Monetary Authority of Singapore's (MAS) Corporate Debt Market Development Report 2025. The report, published on Thursday (Aug 7), showed that in 2024, issuance volumes in Singapore – for long-term total Singdollar and non-Singdollar bonds – hit US$75 billion, 15 per cent higher than the average issuance volumes in the past five years. Excluding a large multi-tranche issuance that resulted in a record issuance volume in 2023, Singapore's bond issuance grew 67.1 per cent year on year in 2024, MAS said. This comes as global bond issuance volume rose to US$9.1 trillion in 2024, amid interest rate cuts which lowered borrowing costs and encouraged issuers to capitalise on more favourable financing conditions. Financial institutions (FIs) remained the leading debt issuers across both Singdollar and non-Singdollar bonds in 2024. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Total outstanding debt arranged by FIs in Singapore rose 9 per cent year on year, to S$617 billion. FIs drove issuances in the non-Singdollar market, with their share increasing 23.7 per cent and issuance volumes rising S$92 billion in 2024, due to the need to fund growth in their asset books. MAS noted that Singapore continued to be an attractive funding destination for global corporates. For the Singdollar market, growth in issuances was broad-based across financial institutions, corporates and statutory boards, supported by lower rates and tighter credit spreads. MAS also pointed out that Singapore is well-positioned to support growth in the digital corporate bond market. While digital bond adoption remains at an early stage relative to traditional bond markets, the technology's potential to enhance efficiency and lower costs indicates promising growth prospects, said the authority. It added that, in 2025, it launched the Global-Asia Digital Bond Grant Scheme to support digital bond issuances and facilitate mainstream adoption. As at the end of 2024, Singapore's digital corporate bond issuance totalled around US$2.5 billion, from a range of issuers including corporations, financial institutions and special purpose vehicles.
Business Times
12 minutes ago
- Business Times
SAP taps Vietnam and Singapore as its dual R&D engines in South-east Asia
[HO CHI MINH CITY] Germany-based enterprise software giant SAP has launched its next digital innovation hub in Ho Chi Minh City on Thursday (Aug 7), with plans to invest more than 150 million euros (S$224.9 million) over the next five years and grow the new centre's headcount to 500 by 2027. This is the Frankfurt Stock Exchange-listed firm's second SAP Labs in South-east Asia after Singapore and the 22nd one globally. Manik Saha, managing director of SAP Labs Singapore and Vietnam, told The Business Times that the firm is focusing on Singapore and Vietnam as its two engineering hubs in South-east Asia, developing products and solutions for global customers, with no foreseeable plans to expand to other locations in the region. 'The flight distance from Singapore to Ho Chi Minh City is about two hours, which means that it's very easy to work together to take the best of both worlds and create even better products,' he said. While the Singapore hub focuses on deep technologies such as artificial intelligence (AI) and machine learning, SAP Labs Vietnam plays a key role in developing SAP's core products, including sustainable digital supply chains and intelligent enterprise solutions. 'I see it as complementary, simply because all these products will need AI embedded into them,' Saha noted, adding that AI experts in Singapore have been flown to Vietnam to deliver some training sessions for local teams. A NEWSLETTER FOR YOU Friday, 8.30 am Asean Business Business insights centering on South-east Asia's fast-growing economies. Sign Up Sign Up Since its establishment in Singapore in 2022, SAP Labs has hired 200 AI engineers in the Republic, out of a total headcount of 420 as at March this year, with most recruited from local universities and institutions of higher learning, including the National University of Singapore (NUS) and Nanyang Technological University (NTU). The same approach to growing its tech workforce in Vietnam has been adopted, with Saha noting that SAP Labs has formed partnerships with three key universities, including the University of Information Technology and the University of Sciences – members of Vietnam National University, Ho Chi Minh City (VNU-HCM), as well as the Vietnamese-German University (VGU). The software giant aims to hire up to 350 people for the new centre in Vietnam in 2025, building on more than 200 employees already onboarded since September 2024. 'Vietnam has a solid quality of engineering graduates,' said Saha. 'We are building a community where we can grow together with engineering and innovation in this location.' Speaking at the launch event, Vietnam's Deputy Prime Minister Nguyen Chi Dung encouraged SAP to continue upskilling and expanding its tech workforce in Vietnam – potentially from 500 to 5,000 – by tapping the strong Vietnamese talent pool in Stem fields, referring to science, technology, engineering and mathematics, both locally and abroad. Meanwhile, SAP is taking a measured approach to scaling up its team. 'We want steady growth in new hires because we aim to maintain a certain level of quality,' said Saha. 'We want product ownership out of Vietnam ... make sure that the people we bring in become global experts in what they do at some point.' As one of the largest European software firms, SAP serves over 440,000 customers in more than 180 countries, including around 700 clients in Vietnam. Its global revenue in FY2024 amounted to 34.18 billion euros, marking a 10 per cent increase compared to the previous year.
